Selective H1-receptor antagonist
This page covers all Selective H1-receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting H1 histamine receptor.
Targets
Marketed (1)
- alcaftadine 0.25% ophthalmic solution · Allergan · Ophthalmology
Alcaftadine is a selective H1-receptor antagonist that blocks histamine-mediated allergic responses in the eye.
Patent intelligence
- selective h1 receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates